Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
about
The role of regulatory T cells in cancer immunologyOntak-like human IL-2 fusion toxin.Emerging Opportunities and Challenges in Cancer Immunotherapy.Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4(+) cells in vivo.DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice.Regulatory T Cells As Potential Targets for HIV Cure Research.
P2860
Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Diphtheria toxin-based bivalen ...... icacy for targeting human CD25
@nl
Diphtheria toxin-based bivalen ...... targeting human CD25(+) cells.
@en
type
label
Diphtheria toxin-based bivalen ...... icacy for targeting human CD25
@nl
Diphtheria toxin-based bivalen ...... targeting human CD25(+) cells.
@en
prefLabel
Diphtheria toxin-based bivalen ...... icacy for targeting human CD25
@nl
Diphtheria toxin-based bivalen ...... targeting human CD25(+) cells.
@en
P2093
P2860
P1476
Diphtheria toxin-based bivalen ...... targeting human CD25(+) cells.
@en
P2093
Christene A Huang
David H Sachs
Huiping Zhang
Jaclyn Stromp Peraino
Joren C Madsen
Priyani V Rajasekera
Zhirui Wang
P2860
P356
10.1016/J.JIM.2014.01.008
P577
2014-01-24T00:00:00Z